Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
Midwifery ; 127: 103865, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37931462

ABSTRACT

INTRODUCTION: To investigate the effectiveness of third-wave cognitive behavior therapies in the treatment of peripartum depression. METHOD: A systematic review of the effectiveness of psychological interventions in treating peripartum depression focus on the Third Wave has been conducted. The electronic databases MEDLINE, PsycINFO, Web of Science and Clinical Trials were searched, using a combination of different search terms. Data were independently extracted by two authors and a synthesis of the results was offered. Methodological quality was assessed by three authors, using ROBE-2 and MINORS. Search date was conducted in February 2022 and the search was re-run in November 2022 for new entries. FINDINGS: Six papers were included and reported, focused on, the effectiveness of Third Wave approach interventions in reducing depressive symptoms. Papers included the following intervention approaches: Behavioral intervention (n = 2), Mindfulness (n = 2), Dialectical Behavior Therapy (n = 1) and Acceptance and Commitment Therapy (n = 1). All six papers were consistent in that interventions lead to a decrease in depression symptoms. However, risk of bias evaluation showed that all were critical low, but one paper was high quality. CONCLUSION AND IMPLICATIONS FOR PRACTICE AND RESEARCH: Systematic review showed that third-wave approaches are promising in effectiveness to reduce depression symptoms in peripartum women. However, more high-quality studies with follow-up are needed.


Subject(s)
Acceptance and Commitment Therapy , Cognitive Behavioral Therapy , Mindfulness , Female , Humans , Peripartum Period , Depression/diagnosis , Cognitive Behavioral Therapy/methods
2.
Rev. med. vet. zoot ; 66(2): 131-140, mayo-ago. 2019. tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1058577

ABSTRACT

RESUMEN El objetivo de este estudio fue estimar parámetros genéticos con y sin la inclusión de parentesco genómico para la producción de leche acumulada a 60 (PL60), 150 (PL150), 210 (PL210) y 305 días (PL305) en ganado Simmental en Colombia. Un total de 2883 controles lecheros en 620 vacas de primer parto fueron utilizados. La información genómica se obtuvo a partir de 718 animales genotipados con un chip de una densidad de 30106 marcadores genéticos tipo polimorfismo de nucleótido simple (SNP). Se construyeron modelos de tipo univariado y bivariado bajo la metodología del mejor predictor lineal insesgado (BLUP) y genómico en una etapa (ssGBLUP). Los valores de heredabilidades para PL60, PL150, PL210 y PL305 variaron entre 0,20 a 0,27; 0,25 a 052; 0,30 a 0,35 y 0,20 a 0,23; respectivamente. La inclusión de parentesco genómico no aumentó las heredabilidades y tampoco la precisión de las estimaciones para las características asociadas a producción de leche. La escasez de información fenotípica y la baja conectividad genética entre la población genotipada y no genotipada podrían limitar procesos de selección genética para producción de leche a través del ssGBLUP en la población de ganado Simmental de Colombia.


ABSTRACT The aim of this study was to estimate genetic parameters with and without the inclusion of genomic relationship in cumulative milk production of Simmental cattle in Colombia for 60 (MP60), 150 (MP150), 210 (MP210) and 305 (MP305) days. A total of 2883 test records from 620 cows in first lactation were used. The genomic information was obtained from 718 animals genotyped with a commercial chip with a density of 30,106 single nucleotide polymorphism (SNP) genetic markers. Univariate and bivariate models were used under the conventional best linear unbiased predictor (BLUP) and the single step genomic BLUP (ssGBLUP) methodologies. The heritability estimate values for MP60, MP150, MP210 and MP305 ranged from 0.20 to 0.27, 0.25 to 0.52, 0.30 to 0.35 and 0.20 to 0.23, respectively. The use of the genomic relationship did not increase heritabilities nor the accuracy of estimates for milk traits. The lack of phenotypic records and the low genetic connectivity between genotyped and non-genotyped populations could limit the genetic selection procedures for milk production via the ssGBLUP in Colombian Simmental cattle.

3.
Arch Soc Esp Oftalmol (Engl Ed) ; 94(5): 218-224, 2019 May.
Article in English, Spanish | MEDLINE | ID: mdl-30846247

ABSTRACT

OBJECTIVE: The purpose of the present study is to describe the clinical characteristics and outcomes of patients diagnosed and treated for conjunctival melanoma in the Ocular Oncology Unit of the University Hospital Clinic of Valladolid. METHODS: A retrospective observational case series study was conducted on patients diagnosed with conjunctival melanoma in the Ocular Oncology Unit of University Hospital Clinic of Valladolid, from January 1992 to December 2017. Demographic information and tumour features were recorded in a Microsoft Access database. RESULTS: Among a total of 462 consecutive patients, the tumour was classified as melanocytic in 252 cases (54.5%), with 27 patients having the pathological diagnosis of conjunctival melanoma. The mean age at diagnosis was 59.2years (16-88), and there were 41% males and 59% females, with a mean follow-up of 6.1±6.8years. As regards the origin of conjunctival melanoma, 16 cases (59%) arose from primary acquired melanosis, 26% from nevus, and 15% developed de novo. The treatment performed was incisional or excisional biopsy in all patients, local adjuvant chemotherapy in 15 cases (56%) and brachytherapy in 5 patients (18%). The median survival was 18years and the probability of survival at 5 and 10years was 89% and 69%, respectively. CONCLUSIONS: Conjunctival melanoma is a rare disease, usually undervalued by the patient as well as being underdiagnosed, leading to insufficient and delayed treatment. Early diagnosis and treatment are essential to prevent recurrences and systemic extension, as well as to preserve vision and life.


Subject(s)
Conjunctival Neoplasms , Melanoma , Adolescent , Adult , Aged , Aged, 80 and over , Conjunctival Neoplasms/diagnosis , Conjunctival Neoplasms/etiology , Conjunctival Neoplasms/therapy , Female , Follow-Up Studies , Humans , Male , Melanoma/diagnosis , Melanoma/etiology , Melanoma/therapy , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Retrospective Studies , Young Adult
4.
Allergol Immunopathol (Madr) ; 46(5): 415-420, 2018.
Article in English | MEDLINE | ID: mdl-29804794

ABSTRACT

BACKGROUND: In children with egg protein allergy (EA), the probability of overcoming the allergy decreases with age, and the possibility of suffering severe adverse reactions as a consequence of dietetic transgressions results in worsened quality of life. One treatment option in such cases is oral immunotherapy (OIT) with foods. METHODS: We present a cohort of children with EA scheduled for OIT with pasteurized raw egg white, describing their clinical and allergic characteristics before the start of OIT. RESULTS: The median age was six years, and 93% of the patients also suffered other allergies (58% asthma and 38.6% allergy to more than two food groups). In the last year, 14.8% had suffered a severe reaction due to dietetic transgression with egg. The median IgE specific of egg white titer was 38.5kU/l. A double-blind placebo-controlled food challenge with cooked egg white was performed, and if the test proved positive, it was repeated with pasteurized raw egg white. The mean symptoms-provoking dose was 1.26g and 0.55g for cooked egg white and raw egg white, respectively. An IgE specific of ovomucoid titer of <2.045kU/l differentiated those patients that tolerated cooked egg white. CONCLUSIONS: OIT with egg is regarded as an option in patients with persistent egg allergy. In the previous challenge test, an IgE specific of ovomucoid titer of <2.045kU/l differentiates those patients that tolerate cooked egg white.


Subject(s)
Egg Hypersensitivity/immunology , Egg White/adverse effects , Administration, Oral , Allergens/adverse effects , Allergens/immunology , Child , Desensitization, Immunologic , Double-Blind Method , Female , Humans , Male
5.
Eur Ann Allergy Clin Immunol ; 49(1): 45-48, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28120607

ABSTRACT

More than 170 foods have been identified as being potentially allergenic. However, a minority of these foods cause the majority of reactions. Sweets are frequently implicated in allergic reactions in children with cow's milk, egg, nuts or fruits allergy, and they are the most relevant foods investigated as responsible allergens. We report an anaphylactic reaction to candies in an egg and peach allergic boy. We performed a study to identify responsible allergens for the reaction. We investigated hidden egg and peach allergens in the candies, but they were not found. Finally, the causative allergen resulted to be a vegetable protein from potato peel. We diagnosed a new allergy in our patient and Sol t 4 was identified as the responsible allergen of the anaphylactic reaction. We conclude that responsible allergens should always be studied and identified in whatever allergic reaction in order to prevent new reactions.


Subject(s)
Allergens/immunology , Anaphylaxis/etiology , Egg Hypersensitivity/immunology , Prunus persica/immunology , Solanum tuberosum/immunology , Humans , Infant , Male , Skin Tests
6.
Eur Ann Allergy Clin Immunol ; 48(4): 123-8, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27425167

ABSTRACT

BACKGORUND: Food allergy is a rare disorder among breastfeeding babies. OBJECTIVE: Our aim was to identify responsible allergens in human milk. METHODS: We studied babies developing allergic symptoms at the time they were breastfeeding. Skin prick tests (SPT) were performed with breast milk and food allergens. Specific IgE was assessed and IgE Immunoblotting experiments with breast milk were carried out to identify food allergens. Clinical evolution was evaluated after a maternal free diet. RESULTS: Five babies had confirmed breast milk allergy. Peanut, white egg and/or cow's milk were demonstrated as the hidden responsible allergens. No baby returned to develop symptoms once mother started a free diet. Three of these babies showed tolerance to other food allergens identified in human milk. CONCLUSION: A maternal free diet should be recommended only if food allergy is confirmed in breastfed babies.


Subject(s)
Allergens/immunology , Breast Feeding/adverse effects , Egg Hypersensitivity/immunology , Milk Hypersensitivity/immunology , Milk Proteins/immunology , Milk, Human/immunology , Peanut Hypersensitivity/immunology , Allergens/adverse effects , Egg Hypersensitivity/diagnosis , Egg Hypersensitivity/diet therapy , Female , Humans , Immunoglobulin E/immunology , Infant , Intradermal Tests , Male , Milk Hypersensitivity/diagnosis , Milk Hypersensitivity/diet therapy , Milk Proteins/adverse effects , Peanut Hypersensitivity/diagnosis , Peanut Hypersensitivity/diet therapy , Predictive Value of Tests , Risk Factors
7.
Neurotoxicology ; 53: 201-214, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26877221

ABSTRACT

It has been claimed that oxidative stress and the production of reactive oxygen radicals can contribute to neuron degeneration and might be one factor in the development of different neurological diseases. In our study, we have attempted to clarify how oxidative damage induces dose dependent changes in functional membrane properties of neurons by means of whole cell patch clamp techniques in brain slices from young adult rats. Our research demonstrates physiological changes in membrane properties of pyramidal motor cortex neurons exposed to 3 concentrations of cumene hydroperoxide (CH; 1, 10 and 100µM) during 30min. Results show that oxidative stress induced by CH evokes important changes, in a concentration and time dependent manner, in the neuronal excitability of motor cortex neurons of the rat: (i) Low concentration of the drug (1µM) already blocks inward rectifications (sag) and decreases action potential amplitude and gain, a drug concentration which has no effects on other neuronal populations, (ii) 10µM of CH depresses the excitability of pyramidal motor cortex neurons by decreasing input resistance, amplitude of the action potential, and gain and maximum frequency of the repetitive firing discharge, and (iii) 100µM completely blocks the capability to produce repetitive discharge of action potentials in all cells. Both larger drug concentrations and/or longer times of exposure to CH narrow the current working range. This happens because of the increase in the rheobase, and the reduction of the cancelation current. The effects caused by oxidative stress, including those produced by the level of lipid peroxidation, are practically irreversible and, this, therefore, indicates that neuroprotective agents should be administered at the first symptoms of alterations to membrane properties. In fact, the pre-treatment with melatonin, acting as an antioxidant, prevented the lipid peroxidation and the physiological changes induced by CH. Larger cells (as estimated by their cell capacitance) were also more susceptible to oxidative stress. Our results provide previously unavailable observations that large size and high sensitivity to oxidative stress (even at low concentrations) make pyramidal neurons of the motor cortex, in particular corticofugal neurons, more susceptible to cell death when compared with other neuronal populations. These results could also shed some light on explaining the causes behind diseases such as Amyotrophic Lateral Sclerosis.


Subject(s)
Benzene Derivatives/pharmacology , Motor Cortex/cytology , Neurons/drug effects , Oxidants/pharmacology , Oxidative Stress/drug effects , Analysis of Variance , Animals , Animals, Newborn , Biophysical Phenomena/drug effects , Biophysics , Dose-Response Relationship, Drug , Electric Stimulation , In Vitro Techniques , Membrane Potentials/drug effects , Patch-Clamp Techniques , Rats , Rats, Wistar , Time Factors
9.
J Anim Sci ; 93(8): 3801-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26440159

ABSTRACT

A multitrait model (MC) and 5 reduced-rank models with principal component structure (components PC, PC, PC, PC, and PC) were compared. The objectives were to determine the most appropriate model for estimating genetic parameters and to evaluate the genetic progress of dual-purpose buffaloes in Colombia using that model. The traits evaluated were weaning weight (WW), yearling weight (W12), weight at 18 mo of age (W18), weight at 2 yr of age (W24), age at first calving (AFC), and milk yield at 270 d of first lactation (MY270). Genealogy and productive information from 34,326 buffaloes born in Colombia between 1997 and 2014 were used. Colombian Association of Buffalo Breeders (ACB) provided the data. Direct additive genetic and residual random effects were included for all the traits. In addition, the maternal additive genetic effect and permanent environmental random effect were included for WW, while a maternal additive genetic effect was included for W12. The fixed effects were contemporary group (farm, year, and calving season: January to April, May to August, or September to December; for all traits) and sex (for WW, W12, W18, and W24). Additionally, parity was included as a fixed effect for WW and W12. Age at weighing was used as a covariate for WW, W12, W18, and W24. Genetic progress of all traits was analyzed using a generalized smooth model (GAM). According to the Akaike information criteria (AIC), the best model was the one with reduced rank and first 3 principal components (PC). This model maintained 100% of the original variance. Genetic parameters estimated with this model were similar to those estimated by MC, but with smaller standard errors. Heritability for weight-related traits ranged between 0.23 and 0.44. Heritabilities for AFC and MY270 were 0.14 and 0.24, respectively. The genetic correlations obtained between all weights (WW, W12, W18, and W24) were positive and high. Correlations between all weights with AFC were negative and moderate. Correlations between all weights with MY270 were positive and moderate, and between MY270 with AFC were negative and low.


Subject(s)
Buffaloes/genetics , Buffaloes/physiology , Reproduction/genetics , Animals , Body Weight/genetics , Colombia , Female , Models, Genetic , Pregnancy , Principal Component Analysis , Selection, Genetic
10.
Allergol Immunopathol (Madr) ; 43(5): 507-26, 2015.
Article in English | MEDLINE | ID: mdl-25800671

ABSTRACT

The present document offers an update on the recommendations for managing patients with cow's milk allergy - a disorder that manifests in the first year of life, with an estimated prevalence of 1.6-3% in this paediatric age group. The main causal allergens are the caseins and proteins in lactoserum (beta-lactoglobulin, alpha-lactoalbumin), and the clinical manifestations are highly variable in terms of their presentation and severity. Most allergic reactions affect the skin, followed by the gastrointestinal and respiratory systems, and severe anaphylaxis may occur. The diagnosis of cow's milk allergy is based on the existence of a suggestive clinical history, a positive allergy study and the subsequent application of controlled exposure testing, which constitutes the gold standard for confirming the diagnosis. The most efficient treatment for cow's milk allergy is an elimination diet and the use of adequate substitution formulas. The elimination diet must include milk from other mammals (e.g., sheep, goat, etc.) due to the risk of cross-reactivity with the proteins of cow's milk. Most infants with IgE-mediated cow's milk allergy become tolerant in the first few years of life. In those cases where cow's milk allergy persists, novel treatment options may include oral immunotherapy, although most authors do not currently recommend this technique in routine clinical practice. Enough evidence is not there to confirm the efficacy of elimination diets in the mother and infant for preventing the appearance of cow's milk allergy. Likewise, no benefits have been observed with prebiotic and probiotic dietetic supplements in infants for preventing food allergy.


Subject(s)
Milk Hypersensitivity , Biomarkers/blood , Desensitization, Immunologic , Diet Therapy/methods , Humans , Immunoglobulin E/blood , Immunoglobulin E/immunology , Milk Hypersensitivity/diagnosis , Milk Hypersensitivity/immunology , Milk Hypersensitivity/therapy , Milk Proteins/adverse effects , Milk Proteins/immunology , Prognosis , Skin Tests
12.
Acta Neurochir (Wien) ; 155(12): 2339-44, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24114077

ABSTRACT

PURPOSE: To evaluate the long-term outcomes of the classical Cloward procedure in single-level cervical spondylosis. METHODS: A retrospective study of 28 patients who were affected by cervical degenerative spondylosis at C4-C7 segments and treated by the Cloward technique at a single level from 1985-1995 was conducted. The average follow-up period was 22 years (range, 17-27 years). Preoperative clinical complaints were recorded and compared to the current clinical status. Preoperative, 3-6 months postoperative and a current radiographic study were analysed by evaluating the segmental and global sagittal alignment of the cervical spine as well as the occurrence of adjacent disc degeneration. RESULTS: The most frequently operated segment was C5-C6 (57.1 %), followed by C6-C7 (32.1 %) and C4-C5 (7.1 %). Pain relief and symptom recovery experienced 3-6 months following the surgery was maintained at the most recent follow-up in 85 % of patients. Adjacent disc degeneration was detected in a total of 17 cases (60.7 %). Overall, a group of 14 cases (50 %) had increased lordosis at C2-C7 at the most recent follow-up, with a mean gain of 1.5º Cobb. According to Odom's criteria, 17 patients (60.8 %) presented with excellent clinical outcome, 6 (21.4 %) presented with good outcome, 5 had a (17.8 %) fair outcome, and none had a poor outcome. CONCLUSIONS: The Cloward technique provided excellent long-term clinical outcome in the treatment of single-level cervical degenerative spondylosis. There were no major alterations of the cervical sagittal balance, and the development of adjacent segment disease (ASD) was not specifically associated with the previous surgery.


Subject(s)
Cervical Vertebrae/surgery , Intervertebral Disc Degeneration/surgery , Intervertebral Disc Displacement/surgery , Radiculopathy/surgery , Spondylosis/surgery , Adult , Age Distribution , Cervical Vertebrae/diagnostic imaging , Female , Follow-Up Studies , Humans , Male , Middle Aged , Radiography , Retrospective Studies , Sex Factors , Spinal Fusion/methods , Time
13.
Allergol. immunopatol ; 41(1): 4-10, ene.-feb. 2013. tab, graf
Article in English | IBECS | ID: ibc-109461

ABSTRACT

Background: Allergen-specific immunotherapy (SIT) is a long-term treatment of respiratory allergy. Objective: To look for early predictors of the effectiveness of Dermatophagoides pteronyssinus SIT. Methods: A prospective multi-centre study was carried out in Spain. Children with D. pteronyssinus rhinitis or asthma were invited to participate. The study was divided into times: T0 (recruitment); T1 (inclusion); T2 a-f (immunotherapy times) and T3 (the end of study). Efficacy of SIT was assessed by clinical scores, visual analogue scales (VAS) and lung function tests. We performed D. pteronyssinus skin tests at T1 and T3, and determined specific serum IgE, IgG4 and IL-10 at T1, T2f and T3.Data were analysed using Mann–Whitney and Kruskal–Wallis tests, compared using Wilcoxon and Chi-square tests, and correlated to Spearman test. All tests had a significance level of 0.05. Results: Thirty-eight children completed the study. At T1 all had rhinitis and 34 also had asthma. At T3, 30 patients had improved, six experienced no changes and two worsened. Improvement was associated to FEV1/FVC and VAS improvement; to a reduction in D. pteronyssinus skin prick test; to a progressive increase in serum levels of D. pteronyssinus IgE, and D. pteronyssinus, Der p1 and Der p2 IgG4. IL-10 levels showed an early increase at T2f (the end of initial build-up immunotherapy phase), and then a reduction at T3 (the end of a year of immunotherapy).Improvement associated to an early increase in IL-10 and was correlated with VAS and specific IgG4 evolution(AU)


Subject(s)
Humans , Male , Female , Child , Adolescent , Interleukin-10/administration & dosage , Interleukin-10/immunology , Interleukin-10/therapeutic use , Dermatophagoides pteronyssinus , Dermatophagoides pteronyssinus/immunology , Antigens, Dermatophagoides , Antigens, Dermatophagoides/immunology , Antigens, Dermatophagoides/isolation & purification , Immunotherapy/methods , Immunotherapy , Interleukin-10/isolation & purification , Interleukin-10/metabolism , Immunotherapy/standards , Immunotherapy/trends , Prospective Studies , Treatment Outcome , Evaluation of the Efficacy-Effectiveness of Interventions
14.
Eur J Neurol ; 20(5): 795-802, 2013 May.
Article in English | MEDLINE | ID: mdl-23278976

ABSTRACT

BACKGROUND AND PURPOSE: Perfusion-computed tomography-source images (PCT-SI) may allow a dynamic assessment of leptomeningeal collateral arteries (LMC) filling and emptying in middle cerebral artery (MCA) ischaemic stroke. We described a regional LMC scale on PCT-SI and hypothesized that a higher collateral score would predict a better response to intravenous (iv) thrombolysis. METHODS: We studied consecutive ischaemic stroke patients with an acute MCA occlusion documented by transcranial Doppler/transcranial color-coded duplex, treated with iv thrombolysis who underwent PCT prior to treatment. Readers evaluated PCT-SI in a blinded fashion to assess LMC within the hypoperfused MCA territory. LMC scored as follows: 0, absence of vessels; 1, collateral supply filling ≤ 50%; 2, between> 50% and < 100%; 3, equal or more prominent when compared with the unaffected hemisphere. The scale was divided into good (scores 2-3) vs. poor (scores 0-1) collaterals. The predetermined primary end-point was a good 3-month functional outcome, while early neurological recovery, transcranial duplex-assessed 24-h MCA recanalization, 24-h hypodensity volume and hemorrhagic transformation were considered secondary end-points. RESULTS: Fifty-four patients were included (55.5% women, median NIHSS 10), and 4-13-23-14 patients had LMC score (LMCs) of 0-1-2-3, respectively. The probability of a good long-term outcome augmented gradually with increasing LMCs: (0) 0%; (1) 15.4%; (2) 65.2%; (3) 64.3%, P = 0.004. Good-LMCs was independently associated with a good outcome [OR 21.02 (95% CI 2.23-197.75), P = 0.008]. Patients with good LMCs had better early neurological recovery (P = 0.001), smaller hypodensity volumes (P < 0.001) and a clear trend towards a higher recanalization rate. CONCLUSIONS: A higher degree of LMC assessed by PCT-SI predicts good response to iv thrombolysis in MCA ischaemic stroke patients.


Subject(s)
Cerebrovascular Circulation/physiology , Collateral Circulation/physiology , Fibrinolytic Agents/therapeutic use , Infarction, Middle Cerebral Artery/physiopathology , Perfusion Imaging , Tissue Plasminogen Activator/therapeutic use , Administration, Intravenous , Aged , Cerebrovascular Circulation/drug effects , Female , Fibrinolytic Agents/administration & dosage , Humans , Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/drug therapy , Male , Prospective Studies , Tissue Plasminogen Activator/administration & dosage , Ultrasonography
15.
Allergol Immunopathol (Madr) ; 41(1): 4-10, 2013.
Article in English | MEDLINE | ID: mdl-22321665

ABSTRACT

BACKGROUND: Allergen-specific immunotherapy (SIT) is a long-term treatment of respiratory allergy. OBJECTIVE: To look for early predictors of the effectiveness of Dermatophagoides pteronyssinus SIT. METHODS: A prospective multi-centre study was carried out in Spain. Children with D. pteronyssinus rhinitis or asthma were invited to participate. The study was divided into times: T0 (recruitment); T1 (inclusion); T2 a-f (immunotherapy times) and T3 (the end of study). Efficacy of SIT was assessed by clinical scores, visual analogue scales (VAS) and lung function tests. We performed D. pteronyssinus skin tests at T1 and T3, and determined specific serum IgE, IgG4 and IL-10 at T1, T2f and T3. Data were analysed using Mann-Whitney and Kruskal-Wallis tests, compared using Wilcoxon and Chi-square tests, and correlated to Spearman test. All tests had a significance level of 0.05. RESULTS: Thirty-eight children completed the study. At T1 all had rhinitis and 34 also had asthma. At T3, 30 patients had improved, six experienced no changes and two worsened. Improvement was associated to FEV1/FVC and VAS improvement; to a reduction in D. pteronyssinus skin prick test; to a progressive increase in serum levels of D. pteronyssinus IgE, and D. pteronyssinus, Der p1 and Der p2 IgG4. IL-10 levels showed an early increase at T2f (the end of initial build-up immunotherapy phase), and then a reduction at T3 (the end of a year of immunotherapy). Improvement associated to an early increase in IL-10 and was correlated with VAS and specific IgG4 evolution.


Subject(s)
Antigens, Dermatophagoides/therapeutic use , Arthropod Proteins/therapeutic use , Asthma/therapy , Cysteine Endopeptidases/therapeutic use , Dermatophagoides pteronyssinus/immunology , Desensitization, Immunologic/methods , Interleukin-10/immunology , Rhinitis, Allergic/therapy , Adolescent , Animals , Antigens, Dermatophagoides/immunology , Arthropod Proteins/immunology , Asthma/immunology , Child , Child, Preschool , Cysteine Endopeptidases/immunology , Female , Humans , Immunoglobulin E/blood , Immunoglobulin G/blood , Male , Prospective Studies , Rhinitis, Allergic/immunology , Spain , Visual Analog Scale
16.
Clin. transl. oncol. (Print) ; 14(5): 350-355, mayo 2012. tab, ilus
Article in English | IBECS | ID: ibc-126908

ABSTRACT

PURPOSE: To assess the results of I-125 episcleral brachytherapy (EB) in uveal melanoma: tumour control, visual acuity (VA), eye preservation and survival. PATIENTS: Prospective and consecutive study of patients with a diagnosis of uveal melanoma at the Ocular Oncology Unit in the Valladolid University Teaching Hospital treated with EB between September 1997 and June 2008. Ocular examination and extraocular and systemic extension data were registered in a database at the time of the diagnosis and during the follow-up. RESULTS: Among a total of 310 patients diagnosed between September 1997 and June 2008, 136 were treated with EB (mean age, 58.3). Mean follow-up was 55.3 months. As for tumour type, 66.9% were nodular and 39% mushroom shaped. With respect to size, 80.9% were medium, 7.4% small and 11.8% large. After 4.6 years of follow-up, tumours were controlled in 97.1%, with a 55.1% reduction in mean height; only 2.9% of patients showed recurrence. VA was maintained in 16.2% of patients and 17.6% showed an increase; 33% had retinopathy and 14.6% optic neuropathy. Only 5.1% of patients underwent enucleation due to complications and there has been 1 melanoma-related death to date. CONCLUSIONS: I-125 EB is effective in tumour control, allowing preservation of the eye and useful visual function for the majority of patients (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Brachytherapy/methods , Brachytherapy , Melanoma/mortality , Uveal Neoplasms/pathology , Scleral Diseases/pathology , Iodine Radioisotopes/therapeutic use , Melanoma/radiotherapy , Scleral Diseases/radiotherapy , Uveal Neoplasms/radiotherapy , Eye Enucleation/methods , Eye Enucleation , Follow-Up Studies , Melanoma/pathology , Neoplasm Staging , Scleral Diseases/mortality , Survival Rate , Treatment Outcome , Uveal Neoplasms/mortality , Visual Acuity/radiation effects
17.
Rev Neurol ; 54(7): 415-9, 2012 Apr 01.
Article in Spanish | MEDLINE | ID: mdl-22451128

ABSTRACT

INTRODUCTION: Thirty per cent of patients with multiple sclerosis (MS) present a suboptimal response to treatment in the first few years. The real impact of the change of treatment has still not been well established. AIMS: To describe our clinical practice with regard to the change of treatment in MS patients with a suboptimal response and to analyse their progress depending on our therapeutic decisions. PATIENTS AND METHODS: The study is observation-based and retrospective. The sample was made up of patients with relapsing-remitting MS and at least one event after establishing immunomodulatory treatment. Both the intention to change treatment and the delays until the actual change took place were taken into account. The theoretical consequences of these strategies were measured by the changes in the expected curve of the Multiple Sclerosis Severity Scale (MSSS). RESULTS: A comparison of those who changed immunomodulator with those that did not showed that 64.3% versus 35.3%, respectively, improved on the expected curve of the MSSS (p > 0.05). Patients who improved the expected curve of the MSSS had changed treatment before those who did not improve (1.9 months versus 6 months), although the differences were not significant. The mean time that elapsed between taking the decision to change and actually changing the treatment was 2.70 ± 3.55 months. CONCLUSIONS: Despite limitations due to the size of the sample, the patients with a suboptimal response who changed treatment early could benefit from an improvement in their expected progression on the MSSS.


Subject(s)
Antirheumatic Agents/therapeutic use , Disease Management , Immunologic Factors/therapeutic use , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Adult , Antirheumatic Agents/administration & dosage , Confounding Factors, Epidemiologic , Female , Glatiramer Acetate , Humans , Immunologic Factors/administration & dosage , Interferon beta-1b , Interferon-beta/administration & dosage , Interferon-beta/therapeutic use , Male , Multiple Sclerosis, Relapsing-Remitting/therapy , Peptides/administration & dosage , Peptides/therapeutic use , Retrospective Studies , Sample Size , Severity of Illness Index , Treatment Outcome
18.
Int J Obstet Anesth ; 20(4): 307-11, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21852106

ABSTRACT

BACKGROUND: Aortocaval compression is a major cause of maternal hypotension. A randomized controlled trial was designed to determine the effectiveness of a mechanical intervention using a right lumbar-pelvic wedge in preventing hypotension after spinal anesthesia for cesarean delivery. METHODS: Eighty healthy women undergoing elective cesarean section were randomly allocated immediately after spinal blockade to either a lumbar-pelvic wedge positioned under the right posterior-superior iliac crest (Wedge group, n=40) or the complete supine position (Supine group, n=40). Hemodynamic values, vasopressor consumption and adverse effects were collected during the surgical procedure. Hypotension was defined as a reduction in systolic blood pressure of 25% from baseline. Patient allocation, management and data collection were performed by a single unblinded anesthetist. RESULTS: There was no difference in the incidence of hypotension between the two groups (42.5% vs. 50%, P=0.51). During the first 5 min, blood pressure decreased less in the Wedge group. There were significant differences in median [interquartile range] vasopressor requirements between the Wedge group and the Supine group (1 [0-2] vs. 3 [1-4] mg, P<0.01) and in nausea during the procedure (6 vs. 22 patients, P<0.01). CONCLUSION: In our study population the use of right lumbar-pelvic wedge was not effective in reducing the incidence of hypotension during spinal anesthesia for cesarean section. Patients in whom the wedge was used had higher systolic blood pressure values during the first 5 min of anesthesia and fewer episodes of nausea. The risk of hypotension remains substantial.


Subject(s)
Anesthesia, Obstetrical/adverse effects , Anesthesia, Spinal/adverse effects , Hypotension/prevention & control , Patient Positioning , Blood Pressure , Cesarean Section , Female , Humans , Pregnancy , Supine Position
19.
Neurocirugia (Astur) ; 21(6): 441-51, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21165541

ABSTRACT

BACKGROUND. The Spanish neurosurgical society created a multicentre data base on spontaneous SAH to analyze the real problematic of this disease in our country. This paper focuses on the group of patients with idiopathic SAH (ISAH). METHODS. 16 participant hospitals collect their spontaneous SAH cases in a common data base shared in the internet through a secured web page, considering clinical, radiological, evolution and outcome variables. The 220 ISAH cases collected from November 2004 to November 2007 were statistically analyzed as a whole and divided into 3 subgroups depending on the CT blood pattern (aneurysmal, perimesencephalic, or normal). RESULTS. The 220 ISAH patients constitute 19% of all 1149 spontaneous SAH collected in the study period. In 46,8% of ISAH the blood CT pattern was aneurysmal, which was related to older age, worse clinical condition, higher Fisher grade, more hydrocephalus and worse outcome, compared to perimesencephalic (42.7%) or normal CT (10.4%) pattern. Once surpassed the acute phase, outcome of ISAH patients is similarly good in all 3 ISAH subgroups, significantly better as a whole compared to aneurysmal SAH patients. The only variable related to outcome in ISAH after a logistic regression analysis was the admission clinical grade. CONCLUSIONS. ISAH percentage of spontaneous SAH is diminishing in Spain. Classification of ISAH cases depending on the blood CT pattern is important to differentiate higher risk groups although complications are not negligible in any of the ISAH subgroups. Neurological status on admission is the single most valuable prognostic factor for outcome in ISAH patients.


Subject(s)
Databases, Factual , Subarachnoid Hemorrhage/diagnosis , Subarachnoid Hemorrhage/etiology , Subarachnoid Hemorrhage/physiopathology , Adult , Aged , Humans , Middle Aged , Registries , Spain/epidemiology , Subarachnoid Hemorrhage/epidemiology
20.
Neurocir. - Soc. Luso-Esp. Neurocir ; 21(6): 441-451, dic. 2010. graf, tab
Article in English | IBECS | ID: ibc-97272

ABSTRACT

Background. The Spanish neurosurgical society created a multicentre data base on spontaneous SAH to analyze the real problematic of this disease in our country. This paper focuses on the group of patients with idiopathic SAH (ISAH).Methods. 16 participant hospitals collect their spontaneous SAH cases in a common data base shared in the internet through a secured web page, considering clinical, radiological, evolution and outcome variables. The 220 ISAH cases collected from November 2004 to November 2007 were statistically analyzed as a whole and divided into 3 subgroups depending on the CT bloodpattern (aneurysmal, perimesencephalic, or normal).Results. The 220 ISAH patients constitute 19% of all 1149 spontaneous SAH collected in the study period. In 46,8% of ISAH the blood CT pattern was aneurysmal, which was related to older age, worse clinical condition, higher Fisher grade, more hydrocephalus and worse outcome, compared to perimesencephalic (42,7%) or normal CT (10,4%) pattern. Once surpassed the acute phase, outcome of ISAH patients is similarly good in all 3 ISAH subgroups, significantly better as a whole compared to aneurysmal SAH patients. The only variable related to outcome in ISAH after a logistic regression analysis was the admission clinical grade. Conclusions. ISAH percentage of spontaneous SAHis diminishing in Spain. Classification of ISAH cases depending on the blood CT pattern is important to differentiate higher risk groups although complications are not negligible in any of the ISAH subgroups. Neurological status on admission is the single most valuable prognostic factor for outcome in ISAH patients (AU)


Propósito. El grupo de trabajo de Patología Vascular de la SENEC desarrolló y mantiene abierta una base de datos multicéntrica que recoge los casos de hemorragia subaracnoidea espontánea. Con esta base se pretende analizar la problemática real que representa esta patología en nuestro medio. Este trabajo se centra en el estudio del grupo de pacientes de la base que presentaron HSA idiopática o de origen no aclarado (HSAI).Materiales y métodos. La base de datos recoge los casos de HSA espontánea de 16 hospitales españoles a través de una página Web compartida en Internet de forma segura. Se consideran variables epidemiológicas ,clínicas y radiológicas, así como la aparición de complicaciones y la evolución de los pacientes. Entre Noviembre de 2004 y Noviembre de 2007 se recogieron 220 pacientes con HSA idiopática. Este grupo se ha analizado estadísticamente de forma global y subdividido en 3 grupos de acuerdo con el patrón TC de sangrado inicial (de tipo aneurismático, perimesencefálico o TCnormal). Resultados. Los 220 pacientes con HSAI representan el 19% del total de 1.149 pacientes con HSA recogidos en la base de datos en el mismo periodo. El 46,8% de los casos de HSAI presentaron patrón de sangrado aneurismático en TC, hecho que se correlacionó con mayor edad, peor condición clínica al ingreso, mayor grado Fisher de sangrado, más frecuencia de hidrocefalia y peor evolución, comparados con los casos de HSAI con sangrado en TC del tipo perimesencefálico (42,7%) o con TC normal (10,4%).Una vez superada la fase aguda, e independientemente del tipo de sangrado inicial, la evolución de los pacientes con HSAI es globalmente buena y significativamente mejor que la de los pacientes con HSA aneurismática. La única variable con valor pronóstico en los casos de HSAI, tras realizar un análisis de (..) (AU)


Subject(s)
Humans , Subarachnoid Hemorrhage/epidemiology , Tomography, X-Ray Computed , Risk Factors , Prognosis , Age and Sex Distribution , Hypertension/epidemiology , Intensive Care Units/statistics & numerical data , Vasospasm, Intracranial/epidemiology , Hydrocephalus/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...